Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $4.80 in the prior trading day, Relay Therapeutics Inc (NASDAQ: RLAY) closed at $4.70, down -2.08%. In other words, the price has decreased by -$2.08 from its previous closing price. On the day, 2.25 million shares were traded. RLAY stock price reached its highest trading level at $4.9299 during the session, while it also had its lowest trading level at $4.665.
Ratios:
Our goal is to gain a better understanding of RLAY by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.42 and its Current Ratio is at 18.42. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on September 10, 2024, Upgraded its rating to Buy and sets its target price to $16 from $10.60 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 28 ’24 when Rahmer Peter sold 1,621 shares for $6.06 per share. The transaction valued at 9,823 led to the insider holds 390,063 shares of the business.
Catinazzo Thomas sold 6,802 shares of RLAY for $41,220 on Oct 28 ’24. The Chief Financial Officer now owns 306,391 shares after completing the transaction at $6.06 per share. On Oct 29 ’24, another insider, Catinazzo Thomas, who serves as the Chief Financial Officer of the company, sold 2,300 shares for $5.95 each. As a result, the insider received 13,685 and left with 304,091 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 803436736 and an Enterprise Value of -3094097. For the stock, the TTM Price-to-Sale (P/S) ratio is 76.95 while its Price-to-Book (P/B) ratio in mrq is 0.94. Its current Enterprise Value per Revenue stands at -0.309 whereas that against EBITDA is 0.008.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $12.14, while it has fallen to a 52-week low of $4.48. The 50-Day Moving Average of the stock is -23.21%, while the 200-Day Moving Average is calculated to be -34.85%.
Shares Statistics:
The stock has traded on average 2.21M shares per day over the past 3-months and 1940730 shares per day over the last 10 days, according to various share statistics. A total of 127.46M shares are outstanding, with a floating share count of 121.92M. Insiders hold about 27.16% of the company’s shares, while institutions hold 73.12% stake in the company. Shares short for RLAY as of 1731628800 were 11611974 with a Short Ratio of 5.25, compared to 1728950400 on 11855809. Therefore, it implies a Short% of Shares Outstanding of 11611974 and a Short% of Float of 8.41.
